Smoking and Diabetes Control in Adults With Type 1 and Type 2 Diabetes: A Nationwide Study From the 2018 National Program for Prevention and Control of Diabetes of Iran

被引:19
作者
Molla, Ghasem Janbabaei [1 ]
Ismail-Beigi, Faramarz [2 ]
Larijani, Bagher [3 ]
Khaloo, Pegah [4 ]
Moosaie, Fatemeh [4 ]
Alemi, Hamid [4 ]
Mansournia, Mohammad Ali [5 ]
Ghadimi, Tayyeb [6 ]
Ghaemi, Fatemeh [7 ]
Nakhjavani, Manouchehr [4 ]
Esteghamati, Alireza [4 ]
机构
[1] Minist Hlth & Med Educ, Curat Affairs, Tehran, Iran
[2] Case Western Reserve Univ, Dept Med Biochem Physiol & Biophys, Div Clin & Mol Endocrinol, Cleveland, OH 44106 USA
[3] Univ Tehran Med Sci, Diabet Researcher Ctr, Endocrinol & Metab Res Inst, Tehran, Iran
[4] Univ Tehran Med Sci, Vali Asr Hosp, Endocrinol & Metab Res Ctr, Sch Med, Tehran, Iran
[5] Univ Tehran Med Sci, Sch Publ Hlth, Dept Epidemiol & Biostat, Tehran, Iran
[6] Iran Med Univ, Dept Surg, Tehran, Iran
[7] Minist Hlth & Med Educ, Dept Transplantat & Dis, Tehran, Iran
关键词
cardiovascular diseases (CVD); diabetes complications; diabetes nephropathies; diabetes retinopathy; glycemic/lipid control; smoking; CIGARETTE-SMOKING; RISK-FACTORS; PROGRESSION; NEUROPATHY; MORTALITY; MELLITUS; DISEASE;
D O I
10.1016/j.jcjd.2019.07.002
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: Smoking is among the top leading causes of morbidity and mortality worldwide. To date, studies on the association between smoking and diabetes complications and metabolic control have shown conflicting results. In this study, we aimed to assess the association of smoking with micro- and macrovascular complications of diabetes and lipid and glycemic indices. Methods: We used the National Program for Prevention and Control of Diabetes of Iran database of 99,651 adult patients with diabetes across Iran. Multiple logistic regression models were used to examine the association between smoking and diabetes complications including cardiovascular disease, neuropathy, nephropathy and retinopathy. This association was adjusted for age, sex, duration of diabetes, glycated hemoglobin (A1C), hypertension, hyperlipidemia, medication, obesity and type of diabetes. Results: Smoking was associated with cardiovascular disease, nephropathy, retinopathy and neuropathy (odds ratios [ORs1 for patients with type 1 diabetes were 1.51, 2.29, 2.70 and 2.40, respectively; for patients with type 2 diabetes, ORs were 1.27, 1.21, 1.51 and 1.70, respectively; all with p values <0.001). Among patients with type 1 diabetes, smoking was significantly (p<0.05) associated with A1C (OR, 2.12), 2-h postglucose level (OR, 1.30), triglycerides (OR, 1.48) and high-density lipoprotein (HDL) control (OR, 1.34). Among patients with type 2 diabetes, smoking was significantly associated with A1C (OR, 1.09) and HDL control (OR, 1.21). Conclusions: Smoking was associated with multiple diabetes complications including cardiovascular disease, neuropathy, nephropathy and retinopathy and worse A1C and HDL control in both patients with type 1 and type 2 diabetes. It was also associated with worse 2-h postglucose level and triglyceride control among patients with type 1 diabetes. Our findings signify that national programs for smoking prevention and cessation may be beneficial to diabetes control in Iran. (C) 2019 Canadian Diabetes Association.
引用
收藏
页码:246 / 252
页数:7
相关论文
共 41 条
  • [1] [Anonymous], [No title captured]
  • [2] Coronary heart disease incidence and mortality, and all-cause mortality among diabetic and non-diabetic people according to their smoking behavior in Finland
    Barengo, Noel C.
    Teuschl, Yvonne
    Moltchanov, Vladislav
    Laatikainen, Tiina
    Jousilahti, Pekka
    Tuomilehto, Jaakko
    [J]. TOBACCO INDUCED DISEASES, 2017, 15
  • [3] Intramuscular Lipid Metabolism in the Insulin Resistance of Smoking
    Bergman, Bryan C.
    Perreault, Leigh
    Hunerdosse, Devon M.
    Koehler, Mary C.
    Samek, Ali M.
    Eckel, Robert H.
    [J]. DIABETES, 2009, 58 (10) : 2220 - 2227
  • [4] The effect of smoking on peripheral insulin sensitivity and plasma endothelin level
    Borissova, AM
    Tankova, T
    Kirilov, G
    Dakovska, L
    Krivoshiev, S
    [J]. DIABETES & METABOLISM, 2004, 30 (02) : 147 - 152
  • [5] Cigarette smoking exacerbates and its cessation ameliorates renal injury in type 2 diabetes
    Chuahirun, T
    Simoni, J
    Hudson, C
    Seipel, T
    Khanna, A
    Harrist, RB
    Wesson, DE
    [J]. AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2004, 327 (02) : 57 - 67
  • [6] Cignarelli M, 2008, J NEPHROL, V21, P180
  • [7] The Effect of Cigarette Smoking on Diabetic Peripheral Neuropathy: A Systematic Review and Meta-Analysis
    Clair, Carole
    Cohen, Marya J.
    Eichler, Florian
    Selby, Kevin J.
    Rigotti, Nancy A.
    [J]. JOURNAL OF GENERAL INTERNAL MEDICINE, 2015, 30 (08) : 1193 - 1203
  • [8] Diabetes in Iran: Prospective Analysis from First Nationwide Diabetes Report of National Program for Prevention and Control of Diabetes (NPPCD-2016)
    Esteghamati, Alireza
    Larijani, Bagher
    Aghajani, Mohammad Haji
    Ghaemi, Fatemeh
    Kermanchi, Jamshid
    Shahrami, Ali
    Saadat, Mohammad
    Esfahani, Ensieh Nasli
    Ganji, Morsaleh
    Noshad, Sina
    Khajeh, Elias
    Ghajar, Alireza
    Heidari, Behnam
    Afarideh, Mohsen
    Mechanick, Jeffrey I.
    Ismail-Beigi, Faramarz
    [J]. SCIENTIFIC REPORTS, 2017, 7
  • [9] Smoking and diabetes-The double health hazard!
    Fagard, Robert H.
    Nilsson, Peter M.
    [J]. PRIMARY CARE DIABETES, 2009, 3 (04) : 205 - 209
  • [10] Smoking and progression of diabetic nephropathy in patients with type 1 diabetes
    Feodoroff, Maija
    Harjutsalo, Valma
    Forsblom, Carol
    Thorn, Lena
    Waden, Johan
    Tolonen, Nina
    Lithovius, Raija
    Groop, Per-Henrik
    [J]. ACTA DIABETOLOGICA, 2016, 53 (04) : 525 - 533